0000899243-16-017315.txt : 20160401
0000899243-16-017315.hdr.sgml : 20160401
20160401161526
ACCESSION NUMBER: 0000899243-16-017315
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160331
FILED AS OF DATE: 20160401
DATE AS OF CHANGE: 20160401
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MUEHL DANIEL W
CENTRAL INDEX KEY: 0001283569
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 161547317
MAIL ADDRESS:
STREET 1: 5 BILLERICA PARK
STREET 2: 101 BILLERICA AVE
CITY: NORTH BILLERCA
STATE: MA
ZIP: 01862
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-03-31
0
0001466301
Clovis Oncology, Inc.
CLVS
0001283569
MUEHL DANIEL W
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY
BOULDER
CO
80301
0
1
0
0
See remarks
Stock option (right to buy)
84.83
2025-07-06
Common Stock
35000
D
Stock option (right to buy)
19.37
2026-03-01
Common Stock
5000
D
Stock option (right to buy)
19.37
2026-03-01
Common Stock
7500
D
Restricted Stock Units
2026-03-01
Common Stock
2500
D
The option shall vest as to 25% of the shares on July 6, 2016, and the remainder shall vest in substantially equal installments over the 48 months immediately following such date.
The option shall vest as to 50% of the shares on March 1, 2017, and the remainder shall vest on March 1, 2018.
The restricted stock units shall vest as to 50% of the units on March 1, 2017, and the remainder shall vest on March 1, 2018.
Each restricted stock unit represents the right to receive one share of Common Stock.
Vice President of Finance, Principal Financial Officer and Principal Accounting Officer
/s/ Daniel W. Muehl
2016-04-01